Akero Therapeutics, Inc. Current Liabilities
Akero Therapeutics, Inc. had Current Liabilities of $47.65 million as of 2025-09-30, per its 10-Q filed 2025-11-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2025-11-07
- 2025-09-30: Liabilities, Current $47.65M.
- 2025-06-30: Liabilities, Current $60.40M.
- 2025-03-31: Liabilities, Current $42.44M.
- 2024-12-31: Liabilities, Current $39.75M.
| Period end | Liabilities, Current |
|---|---|
| 2025-09-30 | $47.65M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $60.40M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $42.44M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $39.75M 10-Q · filed 2025-11-07 |
| 2024-09-30 | $43.29M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $31.17M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $30.26M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $19.13M 10-K · filed 2025-02-28 |
| 2023-09-30 | $28.45M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $21.60M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $16.68M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $19.08M 10-K · filed 2024-02-29 |
| 2022-09-30 | $25.24M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $26.70M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $22.10M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $25.13M 10-K · filed 2023-03-17 |
| 2021-09-30 | $23.54M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $16.46M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $10.14M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $13.11M 10-K · filed 2022-02-25 |
| 2020-09-30 | $12.01M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $10.39M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $8.29M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $9.37M 10-K · filed 2021-03-16 |
| 2019-09-30 | $6.72M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $4.74M 10-Q · filed 2019-08-12 |
| 2018-12-31 | $2.34M 10-K · filed 2020-03-16 |